Acute systemic toxicity
- PMID: 12388848
- DOI: 10.1093/ilar.43.suppl_1.s27
Acute systemic toxicity
Abstract
Use of the test that aimed to identify the single lethal dose of a substance that kills half the animals in a test group (the LD50 test) should finally be discontinued by the end of 2002, after many years of controversy and debate. In its stead are three recently developed alternative animal tests that significantly improve animal welfare: the fixed dose procedure, the acute toxic class method, and the up and down procedure. These tests have already undergone revision, both to improve their scientific performance and, importantly, to increase their regulatory acceptance. They can now be used within a strategy of acute toxicity testing for all types of test substances and for all regulatory and in-house purposes. In vitro cytotoxicity tests could be used (perhaps by mid-2002) as adjuncts to these alternative animal tests to improve dose level selection and reduce (at least modestly) the number of animals used. However, the total replacement of animal tests requires a considerable amount of further test development, followed by validation, which will require at least 10 yr.
Similar articles
-
Acute systemic toxicity--prospects for tiered testing strategies.Toxicol In Vitro. 2004 Apr;18(2):227-30. doi: 10.1016/s0887-2333(03)00143-7. Toxicol In Vitro. 2004. PMID: 14757114
-
The integrated acute systemic toxicity project (ACuteTox) for the optimisation and validation of alternative in vitro tests.Altern Lab Anim. 2007 Mar;35(1):33-8. doi: 10.1177/026119290703500102. Altern Lab Anim. 2007. PMID: 17411349
-
Alternative methods for the median lethal dose (LD(50)) test: the up-and-down procedure for acute oral toxicity.ILAR J. 2002;43(4):233-43. doi: 10.1093/ilar.43.4.233. ILAR J. 2002. PMID: 12391399
-
The international symposium on regulatory testing and animal welfare: recommendations on best scientific practices for acute systemic toxicity testing.ILAR J. 2002;43 Suppl:S108-11. ILAR J. 2002. PMID: 12388862 Review. No abstract available.
-
Humane endpoints and acute toxicity testing.ILAR J. 2000;41(2):114-23. doi: 10.1093/ilar.41.2.114. ILAR J. 2000. PMID: 11406704 Review. No abstract available.
Cited by
-
The Pivotal Role of Preclinical Animal Models in Anti-Cancer Drug Discovery and Personalized Cancer Therapy Strategies.Pharmaceuticals (Basel). 2024 Aug 9;17(8):1048. doi: 10.3390/ph17081048. Pharmaceuticals (Basel). 2024. PMID: 39204153 Free PMC article. Review.
-
Study on the Effect of Oral Administration of Bacteriophages in Charles Foster Rats With Special Reference to Immunological and Adverse Effects.Front Pharmacol. 2021 Apr 12;12:615445. doi: 10.3389/fphar.2021.615445. eCollection 2021. Front Pharmacol. 2021. Retraction in: Front Pharmacol. 2021 Dec 22;12:824722. doi: 10.3389/fphar.2021.824722. PMID: 33912038 Free PMC article. Retracted.
-
Microfabricated electrochemical cell-based biosensors for analysis of living cells in vitro.Biosensors (Basel). 2012 Apr 25;2(2):127-70. doi: 10.3390/bios2020127. Biosensors (Basel). 2012. PMID: 25585708 Free PMC article. Review.
-
In vivo toxic studies and biodistribution of near infrared sensitive Au-Au(2)S nanoparticles as potential drug delivery carriers.J Mater Sci Mater Med. 2008 Jul;19(7):2581-8. doi: 10.1007/s10856-007-3210-7. Epub 2007 Aug 1. J Mater Sci Mater Med. 2008. PMID: 17665103
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources